Literature DB >> 19001119

Preparation and stability of voriconazole eye drop solution.

Antoine Dupuis1, Nicolas Tournier, Gwenaël Le Moal, Nicolas Venisse.   

Abstract

The combined systemic and topical administration of voriconazole has successfully been used to treat keratomycosis. Because no voriconazole eye drop product is commercially available, we prepared a sterile eye drop solution (10 mg/ml). Voriconazole remains stable over 30 days, providing an eye drop solution suitable for use for the topical treatment of fungal keratitis.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19001119      PMCID： PMC2630666          DOI： 10.1128/AAC.01126-08

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  13 in total

1.  Severe keratomycosis secondary to Scedosporium apiospermum.

Authors:  David Díaz-Valle; J M Benitez del Castillo; Elisa Amor; Nicolás Toledano; Manuel Moriche Carretero; Teresa Díaz-Valle
Journal:  Cornea       Date:  2002-07       Impact factor: 2.651

2.  Use of voriconazole in Scedosporium apiospermum keratitis.

Authors:  Tze Foon Lai; Raman Malhotra; Ramin Esmail-Zaden; Anna Galanopoulas; Mark Chehade; Dinesh Selva
Journal:  Cornea       Date:  2003-05       Impact factor: 2.651

3.  A rapid HPLC assay for voriconazole in human plasma.

Authors:  R Gage; D A Stopher
Journal:  J Pharm Biomed Anal       Date:  1998-09       Impact factor: 3.935

Review 4.  Ophthalmic drug delivery systems--recent advances.

Authors:  C L Bourlais; L Acar; H Zia; P A Sado; T Needham; R Leverge
Journal:  Prog Retin Eye Res       Date:  1998-01       Impact factor: 21.198

5.  Voriconazole concentration in human aqueous humor and plasma during topical or combined topical and systemic administration for fungal keratitis.

Authors:  Michael A Thiel; Annelies S Zinkernagel; Jürgen Burhenne; Claude Kaufmann; Walter E Haefeli
Journal:  Antimicrob Agents Chemother       Date:  2006-10-23       Impact factor: 5.191

6.  Avoiding common flaws in stability and compatibility studies of injectable drugs.

Authors:  L A Trissel
Journal:  Am J Hosp Pharm       Date:  1983-07

7.  Topical and oral voriconazole in the treatment of fungal keratitis.

Authors:  Vatinee Y Bunya; Kristin M Hammersmith; Christopher J Rapuano; Brandon D Ayres; Elisabeth J Cohen
Journal:  Am J Ophthalmol       Date:  2006-08-31       Impact factor: 5.258

Review 8.  Voriconazole : a review of its use in the management of invasive fungal infections.

Authors:  Lesley J Scott; Dene Simpson
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 9.  Fungal keratitis caused by Scedosporium apiospermum: report of two cases and review of treatment.

Authors:  Ziqiang Wu; Howard Ying; Samuel Yiu; John Irvine; Ronald Smith
Journal:  Cornea       Date:  2002-07       Impact factor: 2.651

10.  Voriconazole in fungal keratitis caused by Scedosporium apiospermum.

Authors:  Carmen Hernández Prats; Francisca Llinares Tello; Amparo Burgos San José; Juan Selva Otaolaurruchi; Juan Pablo Ordovás Baines
Journal:  Ann Pharmacother       Date:  2004-01-30       Impact factor: 3.154
View more
  9 in total

1.  Comparison of natamycin and voriconazole for the treatment of fungal keratitis.

Authors:  Namperumalsamy V Prajna; Jeena Mascarenhas; Tiruvengada Krishnan; P Ravindranath Reddy; Lalitha Prajna; Muthiah Srinivasan; C M Vaitilingam; Kevin C Hong; Salena M Lee; Stephen D McLeod; Michael E Zegans; Travis C Porco; Thomas M Lietman; Nisha R Acharya
Journal:  Arch Ophthalmol       Date:  2010-06

2.  The efficacy of voriconazole in 24 ocular Fusarium infections.

Authors:  P Troke; G Obenga; T Gaujoux; P Goldschmidt; A-L Bienvenu; M Cornet; F Grenouillet; D Pons; S Ranque; K Sitbon; C Chaumeil; V Borderie; O Lortholary
Journal:  Infection       Date:  2012-06-21       Impact factor: 3.553

Review 3.  Melanized fungi in human disease.

Authors:  Sanjay G Revankar; Deanna A Sutton
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

4.  Development and clinical evaluation of clotrimazole-β-cyclodextrin eyedrops for the treatment of fungal keratitis.

Authors:  Bazigha K Abdul Rasool; Hiba M Salmo
Journal:  AAPS PharmSciTech       Date:  2012-06-14       Impact factor: 3.246

5.  Fungal keratitis secondary to Scedosporium apiospermum infection and successful treatment with surgical and medical intervention.

Authors:  Burcin Kepez Yildiz; Murat Hasanreisoglu; Zeynep Aktas; Gulsah Aksu; Burcak Comert Kocak; Fikret Akata
Journal:  Int Ophthalmol       Date:  2013-04-24       Impact factor: 2.031

6.  Clinical utility of voriconazole eye drops in ophthalmic fungal keratitis.

Authors:  Daoud Al-Badriyeh; Chin Fen Neoh; Kay Stewart; David C M Kong
Journal:  Clin Ophthalmol       Date:  2010-05-06

7.  Voriconazole Composited Polyvinyl Alcohol/Hydroxypropyl-β-Cyclodextrin Nanofibers for Ophthalmic Delivery.

Authors:  Xiaoyi Sun; Zhenwei Yu; Zhengyuan Cai; Lingyan Yu; Yuanyuan Lv
Journal:  PLoS One       Date:  2016-12-14       Impact factor: 3.240

8.  Hp-β-CD-voriconazole in situ gelling system for ocular drug delivery: in vitro, stability, and antifungal activities assessment.

Authors:  Pravin Pawar; Heena Kashyap; Sakshi Malhotra; Rakesh Sindhu
Journal:  Biomed Res Int       Date:  2013-05-09       Impact factor: 3.411

9.  Design and Evaluation of Voriconazole Eye Drops for the Treatment of Fungal Keratitis.

Authors:  Sakshi Malhotra; Anubha Khare; Kanchan Grover; Inderbir Singh; Pravin Pawar
Journal:  J Pharm (Cairo)       Date:  2014-04-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.